SANUWAVE Health, Inc. Common Stock Total Assets
SANUWAVE Health, Inc. Common Stock total assets. Based on the latest financial reports, SANUWAVE Health, Inc. Common Stock (SNWV) holds total assets worth $37.10 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of SANUWAVE Health, Inc. Common Stock for the company's overall valuation and market capitalisation.
Total Assets of SANUWAVE Health, Inc. Common Stock (2006–2025)
Total assets of SANUWAVE Health, Inc. Common Stock from 2006 to 2025. This chart illustrates how SANUWAVE Health, Inc. Common Stock's total assets have evolved over time, based on quarterly financial data. See SANUWAVE Health, Inc. Common Stock (SNWV) share price today for real-time trading data and today's change.
SANUWAVE Health, Inc. Common Stock - Asset Composition Analysis
SANUWAVE Health, Inc. Common Stock Total Assets Breakdown (December 2025)
SANUWAVE Health, Inc. Common Stock total assets breakdown as of December 2025. SANUWAVE Health, Inc. Common Stock's total assets of $37.10 Million consist of 66.0% current assets and 34.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 32.0% |
| Accounts Receivable | $5.42 Million | 14.5% |
| Inventory | $5.93 Million | 15.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $3.03 Million | 8.1% |
| Goodwill | $7.26 Million | 19.4% |
Asset Composition Trend (2006–2025)
This chart illustrates how SANUWAVE Health, Inc. Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is SANUWAVE Health, Inc. Common Stock's working capital to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: SANUWAVE Health, Inc. Common Stock's current assets represent 66.0% of total assets in 2025, a decrease from 100.0% in 2006.
- Cash Position: Cash and equivalents constituted 32.0% of total assets in 2025, down from 100.0% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 27.0% of total assets, an increase from 0.0% in 2006.
- Asset Diversification: The largest asset category is goodwill at 19.4% of total assets.
SANUWAVE Health, Inc. Common Stock Competitors by Total Assets
Key competitors of SANUWAVE Health, Inc. Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
SANUWAVE Health, Inc. Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.31 | 0.40 | 0.11 |
| Quick Ratio | 0.99 | 0.28 | 0.06 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $5.65 Million | $-28.44 Million | $-38.55 Million |
SANUWAVE Health, Inc. Common Stock - Advanced Valuation Insights
This section examines the relationship between SANUWAVE Health, Inc. Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 49.87 |
| Latest Market Cap to Assets Ratio | 1.37 |
| Asset Growth Rate (YoY) | 24.0% |
| Total Assets | $37.34 Million |
| Market Capitalization | $50.99 Million USD |
Valuation Analysis
Above Book Valuation: The market values SANUWAVE Health, Inc. Common Stock's assets above their book value (1.37x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: SANUWAVE Health, Inc. Common Stock's assets grew by 24.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for SANUWAVE Health, Inc. Common Stock (2006–2025)
The table below shows the annual total assets of SANUWAVE Health, Inc. Common Stock from 2006 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $37.34 Million | +23.98% |
| 2024-12-31 | $30.12 Million | +34.36% |
| 2023-12-31 | $22.42 Million | +12.80% |
| 2022-12-31 | $19.87 Million | +6.74% |
| 2021-12-31 | $18.62 Million | -19.14% |
| 2020-12-31 | $23.03 Million | +580.89% |
| 2019-12-31 | $3.38 Million | +187.16% |
| 2018-12-31 | $1.18 Million | -7.90% |
| 2017-12-31 | $1.28 Million | +27.26% |
| 2016-12-31 | $1.00 Million | +4.85% |
| 2015-12-31 | $958.36K | -79.46% |
| 2014-12-31 | $4.67 Million | +193.84% |
| 2013-12-31 | $1.59 Million | -14.18% |
| 2012-12-31 | $1.85 Million | -69.99% |
| 2011-12-31 | $6.17 Million | +103.55% |
| 2010-12-31 | $3.03 Million | -48.37% |
| 2009-12-31 | $5.87 Million | +181768.72% |
| 2008-12-31 | $3.23K | -37.35% |
| 2007-12-31 | $5.15K | -82.96% |
| 2006-12-31 | $30.22K | -- |
About SANUWAVE Health, Inc. Common Stock
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses no… Read more